<DOC>
	<DOCNO>NCT02901990</DOCNO>
	<brief_summary>This study aim conduct 3-year perspective study observe immunological effect one-dose mumps-containing vaccine , monitor incidence mumps vaccinate population age 2-7 yearsï¼Œand provide basis adjust MMR immunization strategy Jiangsu province , China .</brief_summary>
	<brief_title>Observational Study Assess Protection Mumps Children Received One-dose Mumps-containing Vaccine</brief_title>
	<detailed_description>2-7 year old child high risk mumps , epidemiological investigation serum IgG antibody level conduct , prospective observational cohort establish population history mumps vaccination , incidence mumps antibody level group observe , relationship different antibody level incidence mumps vaccinate analyzed , explore attenuation mumps IgG antibody level body , S79 vaccine strain F genotype mumps ' antigenic cross-reactivity protective effect antibody .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Children age 27 year old ; 2. local resident child live least 3 month ; 3. physical health , vaccinate least dose MuV 1. administer MuV ; 2. refuse collect venous blood ; 3. infected mumps ; 4. serious illness reason participate study clinical evaluation</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>mumps</keyword>
	<keyword>immunity</keyword>
	<keyword>cohort study</keyword>
	<keyword>child</keyword>
	<keyword>vaccine</keyword>
</DOC>